Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels

Journal of Alzheimer's Disease

Volumn 35, Issue 4, 2013, Pages 715-726

  Arenaza Urquijo, Eider M ^a   Molinuevo, José Luis ^c   Sala Llonch, Roser ^a   Solé Padullés, Cristina ^c   Balasa, Mircea ^c   Bosch, Beatriz ^c   Olives, Jaume ^c   Antonell, Anna ^c   Lladó, Albert ^c   Sánchez Valle, Raquel ^c   Rami, Lorena ^a,b   Bartres Faz, David ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Aging; amyloid; cognitive reserve; hippocampus; structural MRI

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN CORTEX ATROPHY; CLINICAL ARTICLE; COGNITIVE RESERVE; CONTROLLED STUDY; DEPTH PERCEPTION; EARLY DIAGNOSIS; FEMALE; FRONTAL LOBE; FUNCTIONAL ASSESSMENT; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; LANGUAGE; LEARNING; LUMBAR PUNCTURE; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOLOGIC TEST; RECALL; SENESCENCE; SUPRAMARGINAL GYRUS; TEMPORAL LOBE; VISION; VOXEL BASED MORPHOMETRY; WECHSLER INTELLIGENCE SCALE;

EID: 84878864602     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121906     Document Type: Article

References (66)

1. Jack CR Jr., Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, WeinerMW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 133, 3336-3348.
2. Jack CR Jr., Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS (2011) Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 68, 1526-1535.
3. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M,Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
4. Bennett DA, Schneider JA, Tang Y, Arnold SE, Wilson RS (2006) The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: A longitudinal cohort study. Lancet Neurol 5, 406-412.
5. Burns A, Tomlinson BE, Mann DM (1997) Observations on the brains of demented old people. B.E.Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205-242.
6. Observations on the brains of non-demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of Neurological Sciences (1968) 7, 331-356.
7. Int J Geriatr Psychiatry 12, 785-790.
8. Davis DG, Schmitt FA,Wekstein DR, Markesbery WR(1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58, 376-388.
9. Hulette CM,Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57, 1168-1174.
10. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45, 358-368.
11. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL (2008) Brain volume decline in aging: Evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 65, 113-120.
12. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131, 665-680.
13. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452.
14. Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D (2011) Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Med 13, 37-43.
15. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC (2007) Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 130, 2837-2844.
16. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31, 1275-1283.
17. Katzman R (1993) Education and the prevalence of dementia and Alzheimer's disease. Neurology 43, 13-20.
18. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 2015-2028.
19. Wilson RS, Barnes LL, Aggarwal NT, Boyle PA, Hebert LE, Mendes de Leon CF, Evans DA (2010) Cognitive activity and the cognitive morbidity of Alzheimer disease. Neurology 75, 990-996.
20. Chételat G, Villemagne VL, Pike KE, Baron J-C, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC (2010) Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 133, 3349-3358.
21. Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M,Montine T, Kaye J (2009) Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 72, 354-360.
22. Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KA (2010) Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 67, 353-364.
23. Roe CM, Mintun MA, Ghoshal N, Williams MM, Grant EA, Marcus DS, Morris JC (2010) Alzheimer disease identification using amyloid imaging and reserve variables: Proof of concept. Neurology 75, 42-48.
24. Rolstad S, Nordlund A, Eckerström C, Gustavsson MH, Zetterberg H, Wallin A (2009) Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment- proof of concept. Dement Geriatr Cogn Disord 27, 194-200.
25. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ (2012) Association of lifetime cognitive engagement and low-amyloid deposition. Arch Neurol 69, 623-629.
26. Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H( 2012) Education increases reserve against Alzheimer's disease-evidence from structural MRI analysis. Neuroradiology 54, 929-938.
27. Bartrés-Faz D, Arenaza-Urquijo EM (2011) Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging. Brain Topogr 24, 340-357.
28. Jagust WJ, Mormino EC (2011) Lifespan brain activity,-amyloid, and Alzheimer's disease. Trends Cogn Sci (Regul Ed) 15, 520-526.
29. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19, 497-510.
30. Coffey CE, Saxton JA, RatcliffG, Bryan RN, Lucke JF (1999) Relation of education to brain size in normal aging: Implications for the reserve hypothesis. Neurology 53, 189-196.
31. Querbes O, Aubry F, Pariente J, Lotterie J-A, Démonet J-F, DuretV, Puel M, Berry I, Fort J-C, Celsis P (2009) Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve. Brain 132, 2036-2047.
32. Bartrés-Faz D, Solé-Padullés C, Junqué C, Rami L, Bosch B, BargallóN, Falcón C, Sánchez-Valle R, Molinuevo JL (2009) Interactions of cognitive reserve with regional brain anatomy and brain function during a working memory task in healthy elders. Biol Psychol 80, 256-259.
33. Foubert-Samier A, Catheline G, Amieva H, Dilharreguy B, Helmer C, Allard M, Dartigues J-F (2012) Education, occupation, leisure activities, and brain reserve: A population-based study. Neurobiol Aging 33, 423.e15-25.
34. Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC,Villar A, Molinuevo JL (2007) Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 24, 274-279.
35. Reisberg H, Ferris SH, Sclan SG (1993) Empirical evaluation of the global deterioration scale for staging Alzheimer's disease. Am J Psychiatry 150, 680-682.
36. Fagan AM, Mintun MA, Shah AR, Aldea P, Roe CM, Mach RH, Marcus D, Morris JC, Holtzman DM (2009) Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease.EMBO Mol Med 1, 371-380.
37. Rami L, Valls-Pedret C, Bartrés-Faz D, Caprile C, Solé-Padullés C, Castellvi M, Olives J, Bosch B, Molinuevo JL (2011) [Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease]. Rev Neurol 52, 195-201.
38. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87-97.
39. Fischl B, Liu A, Dale AM (2001) Automated manifold surgery: Constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20, 70-80.
40. Ségonne F, Pacheco J, FischlB(2007) Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 26, 518-529.
41. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194.
42. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97, 11050-11055.
43. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1), S208-S219.
44. Smith SM(2002) Fast robust automated brain extraction.Hum Brain Mapp 17, 143-155.
45. Zhang Y, Brady M, Smith S (2001) Segmentation of brainMR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20, 45-57.
46. Desikan RS, McEvoy LK, Thompson WK, Holland D, Roddey JC, Blennow K, Aisen PS, Brewer JB, Hyman BT, Dale AM (2011) Amyloid-associated volume loss occurs only in the presence of phospho-tau. Ann Neurol 70, 657-661.
47. Desikan RS,McEvoy LK, Thompson WK,Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM (2012) Amyloid- associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol 69, 709-713.
48. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA (2011) Amyloid-associated cortical thinning in clinically normal elderly. Ann Neurol 69, 1032-1042.
49. Fortea J, Sala-Llonch R, Bartrés-Faz D, Lladó A, Solé-Padullés C, Bosch B, Antonell A, Olives J, Sanchez-Valle R, Molinuevo JL, Rami L (2011) Cognitively preserved subjects with transitional cerebrospinal fluid-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas. Biol Psychiatry 70, 183-190.
50. Storandt M, Mintun MA, Head D, Morris JC (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition. Arch Neurol 66, 1476-1481.
51. Protas HD, Chen K, Langbaum JBS, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM (2013) Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMANeurol 70, 320-325.
52. Mormino EC, Kluth JT,Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ (2009) Episodic memory loss is related to hippocampalmediated beta-amyloid deposition in elderly subjects. Brain 132, 1310-1323.
53. Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8, 448-460.
54. Shi F, Liu B, Zhou Y, Yu C, Jiang T (2009) Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus 19, 1055-1064.
55. Blankstein U, Chen JYW, Mincic AM, McGrath PA, Davis KD (2009) The complex minds of teenagers: Neuroanatomy of personality differs between sexes. Neuropsychologia 47, 599-603.
56. Voets NL, Hough MG, Douaud G, Matthews PM, James A, Winmill L, Webster P, Smith S (2008) Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. Neuroimage 43, 665-675.
57. Hutton C, Draganski B, Ashburnerx J, Weiskopf N (2009) A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. NeuroImage 48, 371-380.
58. Pereira JB, Ibarretxe-Bilbao N, Marti M-J, Compta Y, Junqué C, Bargallo N, Tolosa E (2012) Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 33, 2521-2534.
59. Hyde KL, Samson F, Evans AC, Mottron L (2010) Neuroanatomical differences in brain areas implicated in perceptual and other core features of autism revealed by cortical thickness analysis and voxel-based morphometry. Hum Brain Mapp 31, 556-566.
60. Valenzuela MJ, Sachdev P, Wen W, Chen X, Brodaty H (2008) Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS ONE 3, e2598.
61. Piras F, Cherubini A, Caltagirone C, Spalletta G (2011) Education mediates microstructural changes in bilateral hippocampus. Hum Brain Mapp 32, 282-289.
62. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM (2007) Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64, 343-349.
63. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63, 693-699.
64. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, De Leon MJ, Doty RL, Stern Y, Pelton GH (2008) Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 64, 871-879.
65. Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hänninen T, Pihlajamäki M, Laakso MP, Hallikainen M, Hämäläinen A,Vanhanen M, Helkala E-L,Vanninen R, Nissinen A, Rossi R, Frisoni GB, Soininen H (2008) MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study. Neurobiol Aging 29, 31-38.
66. Jacobs HIL, Van Boxtel MPJ, Jolles J, Verhey FRJ, Uylings HBM (2012) Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings. Neurosci Biobehav Rev 36, 297-309.